[{"address1": "1489 West Warm Springs Road", "address2": "Suite 110", "city": "Henderson", "state": "NV", "zip": "89014", "country": "United States", "phone": "646 650 1351", "website": "https://www.volition.com", "industry": "Diagnostics & Research", "sector": "Healthcare", "longBusinessSummary": "VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.", "fullTimeEmployees": 110, "companyOfficers": [{"maxAge": 1, "name": "Dr. Martin Charles Faulkes Ph.D.", "age": 79, "title": "Executive Chairman", "yearBorn": 1944, "fiscalYear": 2023, "totalPay": 239507, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Cameron  Reynolds MBA", "age": 52, "title": "Founder, CEO, President & Director", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 572434, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gaetan  Michel Ph.D.", "age": 49, "title": "Chief Operating Officer", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 518149, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Salvatore Thomas Butera DVM", "age": 71, "title": "Chief Executive Officer of Volition Veterinary Diagnostics Development LLC", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 477253, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Terig  Hughes", "age": 52, "title": "CFO & Treasurer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 338736, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jacob Vincent Micallef MBA, Ph.D.", "age": 67, "title": "Chief Scientific Officer", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 571554, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nicholas  Plummer", "age": 52, "title": "Group General Counsel", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Louise Batchelor  Day", "age": 51, "title": "Group Chief Marketing & Communications Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas  Bygott", "title": "Sales & Marketing Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gael  Forterre M.B.A.", "age": 41, "title": "Chief Commercial Officer", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.8, "open": 0.7869, "dayLow": 0.77, "dayHigh": 0.8, "regularMarketPreviousClose": 0.8, "regularMarketOpen": 0.7869, "regularMarketDayLow": 0.77, "regularMarketDayHigh": 0.8, "beta": 1.262, "forwardPE": -2.9615386, "volume": 75235, "regularMarketVolume": 75235, "averageVolume": 194712, "averageVolume10days": 175910, "averageDailyVolume10Day": 175910, "bid": 0.77, "ask": 0.85, "bidSize": 800, "askSize": 1400, "marketCap": 63774860, "fiftyTwoWeekLow": 0.55, "fiftyTwoWeekHigh": 1.79, "priceToSalesTrailing12Months": 82.25809, "fiftyDayAverage": 0.7932, "twoHundredDayAverage": 0.9023, "currency": "USD", "enterpriseValue": 45769216, "floatShares": 62691262, "sharesOutstanding": 82824496, "sharesShort": 654829, "sharesShortPriorMonth": 493617, "sharesShortPreviousMonthDate": 1711584000, "dateShortInterest": 1714435200, "sharesPercentSharesOut": 0.008, "heldPercentInsiders": 0.23900999, "heldPercentInstitutions": 0.08128, "shortRatio": 2.23, "shortPercentOfFloat": 0.0105, "bookValue": -0.095, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -35319080, "trailingEps": -0.5, "forwardEps": -0.26, "enterpriseToRevenue": 59.034, "enterpriseToEbitda": -1.314, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "VNRX", "underlyingSymbol": "VNRX", "shortName": "VolitionRX Limited", "longName": "VolitionRx Limited", "firstTradeDateEpochUtc": 1330698600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f2470521-bd30-36bc-8cb5-7a13c6a402d8", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.77, "targetHighPrice": 4.5, "targetLowPrice": 2.5, "targetMeanPrice": 3.73, "targetMedianPrice": 3.95, "recommendationMean": 2.2, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 20729984, "totalCashPerShare": 0.253, "ebitda": -34835160, "totalDebt": 5857836, "quickRatio": 0.659, "currentRatio": 0.686, "totalRevenue": 775302, "revenuePerShare": 0.011, "returnOnAssets": -0.97273004, "freeCashflow": -5476800, "operatingCashflow": -18063000, "revenueGrowth": 1.038, "grossMargins": 1.0, "operatingMargins": -35.825993, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-19"}]